Analytical and Bioanalytical Chemistry

, Volume 389, Issue 5, pp 1397–1407 | Cite as

Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy

  • Matthew B. RenfrowEmail author
  • C. Logan Mackay
  • Michael J. Chalmers
  • Bruce A. Julian
  • Jiri Mestecky
  • Mogens Kilian
  • Knud Poulsen
  • Mark R. Emmett
  • Alan G. Marshall
  • Jan Novak
Paper in Forefront


IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis. In IgAN, IgA1 molecules with incompletely galactosylated O-linked glycans in the hinge region (HR) are present in mesangial immunodeposits and in circulating immune complexes. It is not known whether the galactose deficiency in IgA1 proteins occurs randomly or preferentially at specific sites. We have previously demonstrated the first direct localization of multiple O-glycosylation sites on a single IgA1 myeloma protein by use of activated ion-electron capture dissociation (AI-ECD) Fourier transform ion cyclotron resonance (FT-ICR) tandem mass spectrometry. Here, we report the analysis of IgA1 O-glycan heterogeneity by use of FT-ICR MS and liquid chromatography FT-ICR MS to obtain unbiased accurate mass profiles of IgA1 HR glycopeptides from three different IgA1 myeloma proteins. Additionally, we report the first AI-ECD fragmentation on an individual IgA1 O-glycopeptide from an IgA1 HR preparation that is reproducible for each IgA1 myeloma protein. These results suggest that future analysis of IgA1 HR from IgAN patients and normal healthy controls should be feasible.


ICR FT-ICR FTMS O-Glycosylation Electron capture dissociation 



The authors thank Monica Stinnett, Stephanie Wall, John P. Quinn, Stacy Hall, Rose Kulhavy, and Rhubell Brown for their excellent technical assistance. We also thank Dr. Kristina Håkansson for helpful discussions. This work was supported by grants from the National Institutes of Health (RR17261, DK61525, DK71802, DK78244, DE13694, DK64400, and DK47322) the National Science Foundation (DMR-00–841730), the University of Alabama at Birmingham, the National High Magnetic Field Laboratory, and Florida State University.


  1. 1.
    Julian BA, Waldo FB, Rifai A, Mestecky J (1988) Am J Med 84:129–132CrossRefGoogle Scholar
  2. 2.
    Emancipator SN (1998) In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall’s pathology of the kidney. Lippincott-Raven, Philadelphia, pp 479–539Google Scholar
  3. 3.
    Barratt J, Feehally J (2005) J Am Soc Nephrol 16:2088–2097CrossRefGoogle Scholar
  4. 4.
    Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S (1993) Contrib Nephrol 104:172–182Google Scholar
  5. 5.
    Novak J, Julian BA, Tomana M, Mestecky J (2001) J Clin Immunol 21:310–327CrossRefGoogle Scholar
  6. 6.
    Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J (2005) J Biol Chem 280:19136–19145CrossRefGoogle Scholar
  7. 7.
    Tarelli E, Smith AC, Hendry BM, Challacombe SJ, Pouria S (2004) Carbohydr Res 339:2329–2335CrossRefGoogle Scholar
  8. 8.
    Coppo R, Amore A (2004) Kidney Int 65:1544–1547CrossRefGoogle Scholar
  9. 9.
    Allen AC, Bailey EM, Brenchley PEC, Buck KS, Barrat J, Feehally J (2001) Kidney Int 60:969–973CrossRefGoogle Scholar
  10. 10.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K (2001) Kidney Int 59:1077–1085CrossRefGoogle Scholar
  11. 11.
    Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J (1999) J Clin Invest 104:73–81CrossRefGoogle Scholar
  12. 12.
    Julian BA, Novak J (2004) Curr Opin Nephrol Hypertens 13:171–179CrossRefGoogle Scholar
  13. 13.
    Julian BA, Tomana M, Novak J, Mestecky J (1999) Adv Nephrol 29:53–72Google Scholar
  14. 14.
    Geyer H, Geyer R (2006) Biochim Biophys Acta 1764:1853–1869Google Scholar
  15. 15.
    Wuhrer M, Deelder AM, Hokke CH (2005) J Chromatogr B Analyt Technol Biomed Life Sci 825:124–133CrossRefGoogle Scholar
  16. 16.
    Carr SA, Huddleston MJ, Bean MF (1993) Protein Sci 2:183–196CrossRefGoogle Scholar
  17. 17.
    Medzihradszky KF (2005) Methods Enzymol 405:116–138CrossRefGoogle Scholar
  18. 18.
    Wang F, Nakouzi A, Angeletti RH, Casadevall A (2003) Anal Biochem 314:266–280CrossRefGoogle Scholar
  19. 19.
    Chalkley RJ, Burlingame AL (2001) J Am Soc Mass Spectrom 12:1106–1113CrossRefGoogle Scholar
  20. 20.
    Itoh S, Kawasaki N, Ohta M, Hayakawa T (2002) J Chromatogr A 978:141–152CrossRefGoogle Scholar
  21. 21.
    Olson FJ, Backstrom M, Karlsson H, Burchell J, Hansson GC (2005) Glycobiology 15:177–191CrossRefGoogle Scholar
  22. 22.
    Liu T, Qian WJ, Gritsenko MA, Camp DG, 2nd, Monroe ME, Moore RJ, Smith RD (2005) J Proteome Res 4:2070–2080CrossRefGoogle Scholar
  23. 23.
    Marshall AG, Hendrickson CL, Jackson GS (1998) Mass Spectrom Rev 17:1–35CrossRefGoogle Scholar
  24. 24.
    Zaia J (2004) Mass Spectrom Rev 23:161–227CrossRefGoogle Scholar
  25. 25.
    Cooper HJ, Håkansson K, Marshall AG (2005) Mass Spectrom Rev 24:201–222CrossRefGoogle Scholar
  26. 26.
    Zubarev RA, Kelleher NL, McLafferty FW (1998) J Am Chem Soc 120:3265–3266CrossRefGoogle Scholar
  27. 27.
    Syka JE, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF (2004) Proc Natl Acad Sci USA 101:9528–9533CrossRefGoogle Scholar
  28. 28.
    Håkansson K, Chalmers MJ, Quinn JP, McFarland MA, Hendrickson CL, Marshall AG (2003) Anal Chem 75:3256–3262CrossRefGoogle Scholar
  29. 29.
    Håkansson K, Cooper HJ, Emmett MR, Costello CE, Marshall AG, Nilsson CL (2001) Anal Chem 73:4530–4536CrossRefGoogle Scholar
  30. 30.
    Hogan JM, Pitteri SJ, Chrisman PA, McLuckey SA (2005) J Proteome Res 4:628–632CrossRefGoogle Scholar
  31. 31.
    Kjeldsen F, Haselmann KF, Budnik BA, Sorensen ES, Zubarev RA (2003) Anal Chem 75:2355–2361CrossRefGoogle Scholar
  32. 32.
    Haselmann KF, Budnik BA, Olsen JV, Nielsen ML, Reis CA, Clausen H, Johnsen AH, Zubarev RA (2001) Anal Chem 73:2998–3005CrossRefGoogle Scholar
  33. 33.
    Mirgorodskaya E, Roepstorff P, Zubarev RA (1999) Anal Chem 71:4431–4436CrossRefGoogle Scholar
  34. 34.
    Mormann M, Paulsen H, Peter-Katalinic J (2005) Eur J Mass Spectrom (Chichester, Eng) 11:497–511CrossRefGoogle Scholar
  35. 35.
    Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M (2002) Kidney Int 62:465–475CrossRefGoogle Scholar
  36. 36.
    Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J (1997) Kidney Int 52:509–516CrossRefGoogle Scholar
  37. 37.
    Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J (2007) Kidney Int 71:1148–1154CrossRefGoogle Scholar
  38. 38.
    Moore JS, Kulhavy R, Tomana M, Moldoveanu Z, Suzuki H, Brown R, Hall S, Kilian M, Poulsen K, Mestecky J, Julian BA, Novak J (2007) Mol Immunol 44:2598–2604CrossRefGoogle Scholar
  39. 39.
    Xu LX, Zhao MH (2005) Kidney Int 68:167–172CrossRefGoogle Scholar
  40. 40.
    Hiki Y, Tanaka A, Kokubo T, Iwase H, Nishikido J, Hotta K, Kobayashi Y (1998) J Am Soc Nephrol 9:577–582Google Scholar
  41. 41.
    Novak J, Tomana M, Kilian M, Coward L, Kulhavy R, Barnes S, Mestecky J (2000) Mol Immunol 37:1047–1056CrossRefGoogle Scholar
  42. 42.
    Tomana M, Prchal JT, Garner LC, Skalka HW, Barker SA (1984) J Lab Clin Med 103:137–142Google Scholar
  43. 43.
    Shevchenko A, Tomas H, Havli Sbreve J, Olsen JV, Mann M (2006) Nat Protoc 1:2856–2860CrossRefGoogle Scholar
  44. 44.
    Shevchenko A, Wilm M, Vorm O, Mann M (1996) Anal Chem 68:850–858CrossRefGoogle Scholar
  45. 45.
    Sullivan B, Addona TA, Carr SA (2004) Anal Chem 76:3112–3118CrossRefGoogle Scholar
  46. 46.
    Senko MW, Hendrickson CL, Pasa-Tolic L, Marto JA, White FM, Guan S, Marshall AG (1996) Rapid Commun Mass Spectrom 10:1824–1828CrossRefGoogle Scholar
  47. 47.
    Blakney GT, van der Rest G, Johnson JR, Freitas MA, Drader JJ, Shi SDH, Hendrickson CL, Kelleher NL, Marshall A (2001) in 49th Amer Soc Mass Spectrom Conf on Mass Spectrom Conf on Mass Spectrom & Allied Topics, Chicago, ILGoogle Scholar
  48. 48.
    Senko MW, Canterbury JD, Guan S, Marshall AG (1996) Rapid Commun Mass Spectrom 10:1839–1844CrossRefGoogle Scholar
  49. 49.
    Chowdhury SK, Katta V, Chait BT (1990) Rapid Commun Mass Spectrom 4:81–87CrossRefGoogle Scholar
  50. 50.
    Senko MW, Hendrickson CL, Emmett MR, Shi SD-H, Marshall AG (1997) J Am Soc Mass Spectrom 8:970–976CrossRefGoogle Scholar
  51. 51.
    Marshall AG, Verdun FR (1990) Fourier transforms in NMR, optical, and mass spectrometry. A user’s handbook. Elsevier, AmsterdamGoogle Scholar
  52. 52.
    Ledford EB, Jr., Rempel DL, Gross ML (1984) Anal Chem 56:2744–2748CrossRefGoogle Scholar
  53. 53.
    Shi SD-H, Drader JJ, Freitas MA, Hendrickson CL, Marshall AG (2000) Int J Mass Spectrom 195/196:591–598CrossRefGoogle Scholar
  54. 54.
    Karnoup AS, Turkelson V, Anderson WH (2005) Glycobiology 15:965–981CrossRefGoogle Scholar
  55. 55.
    Robinson EW, Leib RD, Williams ER (2006) J Am Soc Mass Spectrom 17:1469–1479CrossRefGoogle Scholar
  56. 56.
    Iwase H, Tanaka A, Hiki Y, Kokubo T, Sano T, Ishii-Karakasa I, Hisatani K, Kobayashi Y, Hotta K (2001) Anal Biochem 288:22–27CrossRefGoogle Scholar
  57. 57.
    Odani H, Hiki Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, Shinzato T, Maeda K (2000) Biochem Biophys Res Commun 271:268–274CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Matthew B. Renfrow
    • 1
    Email author
  • C. Logan Mackay
    • 2
    • 7
  • Michael J. Chalmers
    • 2
    • 8
  • Bruce A. Julian
    • 3
    • 4
  • Jiri Mestecky
    • 3
    • 4
  • Mogens Kilian
    • 5
  • Knud Poulsen
    • 5
  • Mark R. Emmett
    • 2
    • 6
  • Alan G. Marshall
    • 2
    • 6
  • Jan Novak
    • 4
  1. 1.UAB Biomedical FT-ICR MS Laboratory, Department of Biochemistry and Molecular GeneticsUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.National High Magnetic Field LaboratoryFlorida State UniversityTallahasseeUSA
  3. 3.Department of MedicineUniversity of Alabama at BirminghamBirminghamUSA
  4. 4.Department of MicrobiologyUniversity of Alabama at BirminghamBirminghamUSA
  5. 5.Department of Medical Microbiology and ImmunologyAarhus UniversityAarhusDenmark
  6. 6.Member of the Department of Chemistry and BiochemistryFlorida State UniversityTallahasseeUSA
  7. 7.Department of ChemistryUniversity of EdinburghEdinburghScotland
  8. 8.Department of Molecular TherapeuticsThe Scripps Research InstituteJupiterUSA

Personalised recommendations